Tenax Therapeutics (TENX) Tops Q1 EPS by 3c

Tenax Therapeutics (NASDAQ: TENX) reported Q1 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Nike names former Pfizer CFO David Denton as new finance chief
• After-Hours Stock Movers: FDX, CBRS, NKE